Literature DB >> 3286516

Bacterial infections of the skin treated with ciprofloxacin.

A Gorkiewicz-Petkow1, H Weuta, S Jablonska, L Petkow, S Bielunska, M Gawkonska.   

Abstract

Bacterial infections of the skin or soft tissue responded to ciprofloxacin 500 mg tablets b.i.d. The treatment was well tolerated and effective, so that this drug can be recommended in cutaneous infections caused by sensitive bacteria.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3286516     DOI： 10.1007/bf01650509

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  9 in total

1.  Treatment of skin, skin structure, bone, and joint infections with ceftazidime.

Authors:  L O Gentry
Journal:  Am J Med       Date:  1985-08-09       Impact factor: 4.965

2.  A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.

Authors:  P H Karakusis; G M Trenholme; S Levin
Journal:  Infection       Date:  1985       Impact factor: 3.553

3.  Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.

Authors:  C H Ramirez-Ronda; S Saavedra; C R Rivera-Vázquez
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

4.  Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.

Authors:  J A Pérez-Ruvalcaba; N P Quintero-Pérez; J J Morales-Reyes; J A Huitrón-Ramírez; J J Rodríguez-Chagollán; E Rodríguez-Noriega
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

5.  Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.

Authors:  L C Parish; R Asper
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

6.  Cephalosporins in cutaneous infections. A prospective comparison of two dosage regimens of ceftazidime for therapy of skin and skin structure infections.

Authors:  L C Parish; J A Witkowski; R Snow; L Eron; W J Mogabgab
Journal:  Int J Dermatol       Date:  1986-05       Impact factor: 2.736

7.  Skin and soft tissue infections: pharmacologic approaches.

Authors:  J L Blumer; C A O'Brien; E Lemon; T M Capretta
Journal:  Pediatr Infect Dis       Date:  1985 May-Jun

8.  Ticarcillin plus clavulanic acid versus moxalactam in the treatment of skin and soft tissue infections.

Authors:  B Rao; R C See; S K Chuah; M B Bansal; M A Lou; H Thadepalli
Journal:  Am J Med       Date:  1985-11-29       Impact factor: 4.965

9.  Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatment.

Authors:  G A Pankey; H P Katner; G T Valainis; M J Clarkson; L M Cortez; J R Dalovisio
Journal:  Am J Med       Date:  1985-11-29       Impact factor: 4.965
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.